These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 28317560)

  • 41. Wilms' tumor 1 protein and estrogen receptor beta expression are associated with poor outcomes in uterine carcinosarcoma.
    Guntupalli SR; Cao D; Shroff R; Gao F; Menias C; Stewart Massad L; Powell MA; Mutch DG; Thaker PH
    Ann Surg Oncol; 2013 Jul; 20(7):2373-9. PubMed ID: 23344579
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Extent of lymph node dissection and overall survival in patients with uterine carcinosarcoma, papillary serous and endometrioid adenocarcinoma: A retrospective cohort study.
    Alagkiozidis I; Weedon J; Grossman A; Wang P; Mize B; Wilson K; Shah T; Economos K; Salame G; Abulafia O; Lee YC
    Int J Surg; 2015 Dec; 24(Pt A):9-13. PubMed ID: 26476418
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Clinical analysis of 12 cases of uterine carcinosarcoma].
    Wang LH; Xiong Y; Li YF; Li JD; Feng YL; Li YJ; Chen C; Chen L
    Ai Zheng; 2008 May; 27(5):516-9. PubMed ID: 18479602
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Survival outcome of women with stage IV uterine carcinosarcoma who received neoadjuvant chemotherapy followed by surgery.
    Matsuo K; Johnson MS; Im DD; Ross MS; Bush SH; Yunokawa M; Blake EA; Takano T; Klobocista MM; Hasegawa K; Ueda Y; Shida M; Baba T; Satoh S; Yokoyama T; Machida H; Ikeda Y; Adachi S; Miyake TM; Iwasaki K; Yanai S; Takeuchi S; Nishimura M; Nagano T; Takekuma M; Shahzad MMK; Pejovic T; Omatsu K; Kelley JL; Ueland FR; Roman LD
    J Surg Oncol; 2018 Mar; 117(3):488-496. PubMed ID: 29044542
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of Adjuvant Therapy on Oncologic Outcomes of Surgically Confirmed Stage I Uterine Carcinosarcoma: a Turkish Gynecologic Oncology Study.
    Kimyon Cömert G; Türkmen O; Boyraz G; Yalçın İ; Altın D; Karalök A; Şahin H; Taşkın S; Başaran D; Fırat Cuylan Z; Koyuncu K; Salman MC; Özgül N; Meydanlı MM; Turan T; Ortaç F; Yüce K
    Balkan Med J; 2019 Jul; 36(4):229-234. PubMed ID: 30873825
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combination of adjuvant chemotherapy and radiotherapy is associated with improved survival at early stage type II endometrial cancer and carcinosarcoma.
    Sozen H; Çiftçi R; Vatansever D; Topuz S; Iyibozkurt AC; Bozbey HU; Yaşa C; Çali H; Yavuz E; Kucucuk S; Aydiner A; Salihoglu Y
    Aust N Z J Obstet Gynaecol; 2016 Apr; 56(2):199-206. PubMed ID: 26890292
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association of Pelvic and Para-Aortic Lymphadenectomy With Survival in Stage I Endometrioid Endometrial Cancer: Matched Cohort Analyses From the National Cancer Database.
    Seagle BL; Kocherginsky M; Shahabi S
    JCO Clin Cancer Inform; 2017 Nov; 1():1-14. PubMed ID: 30657385
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Impact of Combined Radiation and Chemotherapy on Outcome in Uterine Clear Cell Carcinoma Compared with Chemotherapy Alone.
    Mahdi H; Moulton L; Nutter B; Cherian S; Rose P
    Clin Oncol (R Coll Radiol); 2016 Dec; 28(12):776-782. PubMed ID: 27339402
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Low-grade and high-grade endometrial stromal sarcoma: A National Cancer Database study.
    Seagle BL; Shilpi A; Buchanan S; Goodman C; Shahabi S
    Gynecol Oncol; 2017 Aug; 146(2):254-262. PubMed ID: 28596015
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chemotherapy, Radiation, or Combination Therapy for Stage III Uterine Cancer.
    Syeda S; Chen L; Hou JY; Tergas AI; Khoury-Collado F; Melamed A; St Clair CM; Ananth CV; Neugut AI; Hershman DL; Wright JD
    Obstet Gynecol; 2019 Jul; 134(1):17-29. PubMed ID: 31188310
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment outcomes in completely resected stage I to stage IV uterine carcinosarcoma with rhabdomyosarcoma differentiation.
    Makker V; Kravetz SJ; Gallagher J; Orodel OP; Zhou Q; Iasonos A; DeLair D; Aghajanian C; Hensley ML
    Int J Gynecol Cancer; 2013 Nov; 23(9):1635-41. PubMed ID: 24172099
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Patterns of failure for conservatively managed surgical stage I uterine carcinosarcoma: implications for adjuvant therapy.
    Leath CA; Numnum TM; Kendrick JE; Frederick PJ; Rocconi RP; Conner MG; Straughn JM
    Int J Gynecol Cancer; 2009 Jul; 19(5):888-91. PubMed ID: 19574779
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Stage III uterine carcinosarcoma: 2009 International Federation of Gynecology and Obstetrics Staging System and Prognostic Determinants.
    Garg G; Kruger M; Christensen C; Deppe G; Toy EP
    Int J Gynecol Cancer; 2011 Dec; 21(9):1606-12. PubMed ID: 21720252
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Patterns of care and outcomes for women with uterine cancer and ovarian metastases.
    Jones NL; Huang Y; Chatterjee S; Tergas AI; Burke WM; Hou JY; Deutsch I; Ananth CV; Neugut AI; Hershman DL; Wright JD
    Int J Gynecol Cancer; 2019 Feb; 29(2):365-376. PubMed ID: 30718315
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Postoperative radiotherapy of uterine sarcoma: a multicentric retrospective study].
    Champetier C; Hannoun-Levi JM; Resbeut M; Azria D; Salem N; Tessier E; Ellis S; Cowen D;
    Cancer Radiother; 2011 Apr; 15(2):89-96. PubMed ID: 20674447
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Survival implications of staging lymphadenectomy for non-endometrioid endometrial cancers.
    Venigalla S; Chowdhry AK; Shalowitz DI
    Gynecol Oncol; 2018 Jun; 149(3):531-538. PubMed ID: 29559170
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy and tolerability of combination cisplatin and ifosfamide chemotherapy with vaginal cuff brachytherapy in the first line treatment of uterine carcinosarcoma.
    Abu-Khalaf MM; Raza MA; Hatzis C; Wang H; Lin K; Higgins S; Ratner E; Silasi DA; Azodi M; Rutherford TJ; Santin AD; Schwartz PE
    Eur J Gynaecol Oncol; 2016; 37(2):199-203. PubMed ID: 27172745
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Post-operative radiotherapy in patients with early stage cervical cancer.
    Dávila Fajardo R; van Os R; Buist MR; Uitterhoeve L; Westermann AM; Kenter GG; Rasch CR; Stalpers LJ
    Gynecol Oncol; 2014 Jul; 134(1):52-9. PubMed ID: 24784874
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of systematic lymphadenectomy and adjuvant therapy in stage I uterine papillary serous carcinoma.
    Thomas MB; Mariani A; Cliby WA; Keeney GA; Podratz KC; Dowdy SC
    Gynecol Oncol; 2007 Nov; 107(2):186-9. PubMed ID: 17688926
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of prognostic factors and treatment outcomes in uterine carcinosarcoma.
    Galaal K; Kew FM; Tam KF; Lopes A; Meirovitz M; Naik R; Godfrey KA; Hatem MH; Edmondson RJ
    Eur J Obstet Gynecol Reprod Biol; 2009 Apr; 143(2):88-92. PubMed ID: 19201517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.